Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2025

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)-- Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the third quarter of 2025 of $1.30 per share on the company’s common stock. The dividend is payable on September 9, 2025 to shareholders of record at the close of business on August 26, 2025. The ex-dividend date is August 26, 2025.

About Johnson & Johnson

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com/.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250715350667/en/

Media:
[email protected]

Investors:
[email protected]

Source: Johnson & Johnson

You May Also Be Interested In

• Seabury Capital Management Announces US$ 2.5 Billion Commitment by the Al Mazroui Group as Anchor Investor to MBV Investments LP Fund – Total of US$ 3.0 Billion in Initial Commitments
• DBGI Forecasts Profitable Q3 2026 with $8.5M to $11M Revenue Driven by Collegiate Expansion & Multi-City Government Rollout 
• SBA Suspends 7,800 Wisconsin Borrowers Connected to $375 Million in Suspected Fraudulent Pandemic-Era Loans